Table I.
Clinical characteristics of three datasets.
| Clinical index | TCGA cohort (n=96) | E-GEOD-53624 (n=119) | E-GEOD-53624 (n=179) |
|---|---|---|---|
| Age, mean ± SD | 58.29±10.24 | 59.03±8.93 | 59.35±9.03 |
| Sex, female/male | 14/82 | 21/98 | 33/146 |
| OS, years, mean ± SD | 1.25±0.96 | 3.09±2.02 | 3.02±1.91 |
| OS status, alive/dead | 63/33 | 46/73 | 73/106 |
| DFS, mean years ± SD) | 1.11±1.02 | – | – |
| DFS status, 0/1/- | 59/32/5 | – | – |
| Stage, I/II/III/IV/- | 7/55/27/4/3 | 8/44/67/0/0 | 10/77/92/0/0 |
| Pathological T, T1/T2/T3/T4/- | 8/31/50/4/3 | 8/20/62/29 | 12/27/110/30 |
| Pathologic N, N0/N1/N2/N3- | 54/29/6/3/4 | 54/42/13/10/0 | 83/62/22/12/0 |
| Pathological M, M0/M1/- | 83/4/9 | – | – |
| Eastern cancer oncology group, 0/1/2/3/- | 3/28/5/3/57 | – | – |
TCGA, The Cancer Genome Atlas; OS, overall survival; SD, standard deviation; DFS, disease-free survival; T, tumor; N; node; M, metastasis.